A Reliance Capital Company
Company Search 45
Open an Account  | Login  | Demo
Friday, December 21, 2007
Real news in Real Time! National and international updates on all products by leading agencies such as Dow Jones, Capital Markets, Commodities Control and more.
Equity   |   Derivatives   |   IPO   |   Commodity   |   Mutual Funds   |   Forex   |   Insurance   |   Mobile

OVERVIEW

Capital Market Live News    Dow Jones News Wire    Derivatives/F&O News    Advanced Search   
Commodity News    Forex News   


Equity News
Dec 19 2007 6:09PM
Sandu Pharmaceuticals net profit rises 1033.33% in the March 2007 quarter

Net profit of Sandu Pharmaceuticals rose 1033.33% to Rs 0.34 crore in the quarter ended March 2007 as against Rs 0.03 crore during the previous quarter ended March 2006. Sales rose 49.24% to Rs 2.94 crore in the quarter ended March 2007 as against Rs 1.97 crore during the previous quarter ended March 2006.

For the full year, net profit rose 7.69% to Rs 1.12 crore in the year ended March 2007 as against Rs 1.04 crore during the previous year ended March 2006. Sales rose 19.34% to Rs 11.97 crore in the year ended March 2007 as against Rs 10.03 crore during the previous year ended March 2006.

Powered byCapital Market - Live News
  Source:   

   Capital Market Disclaimer
Back
 
 
News
 
Research
 
Markets
 
Knowledge Center
 
Charting
 
Customer Service
 
Contact Us
 
Site Map
 
SEBI | BSE | NSE
Terms & Conditions | Disclaimer | Online Privacy | Trouble Logging in
Copyright© 2007. All rights Reserved. Reliance Money Limited
Equities: Trading through Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 | BSE SEBI
Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 Commodities : Trading through Reliance Commodities Limited | MCX member code: 29030 | NCDEX member code: NCDEX-CO-05-00647|
NMCE member code: CL0120 Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances please write to [email protected]
In case of any queries/ complaints with respect to stock broking transactions executed on this website or pertaining account opening, Pl.address your correspondence to Reliance Securities Limited.